Fortine

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fortine

Quick Facts

Property Description
Active ingredient Flurbiprofen
Form Film Tablet (Oral), Lozenge, Topical Gel, Ophthalmic Solution
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use (General) Symptomatic relief of pain, inflammation, and fever
Origin Synthetic (Propionic Acid Derivative)

What Type of Medicine is Fortine and Its Core Classification?

Fortine is a specific brand name for a medicinal product containing the active ingredient flurbiprofen, which is clinically recognized as a potent compound within the Nonsteroidal Anti-Inflammatory Drug (NSAID) pharmacological class. Flurbiprofen is a synthetic compound, classified as a propionic acid derivative, placing it structurally alongside related NSAIDs like ibuprofen.

This medicine is primarily known in the form of a film tablet designed for oral administration, a format which allows for systemic action throughout the body. Flurbiprofen is available globally in multiple specialized forms, including lozenges and ophthalmic solutions, providing the flexibility for targeted treatment delivery. The product is always a single-component product, with its therapeutic action stemming entirely from the flurbiprofen itself.

Flurbiprofen: Mechanism and General Therapeutic Purpose

The fundamental therapeutic purpose of Fortine is to provide analgesic, anti-inflammatory, and antipyretic effects, offering comprehensive symptomatic relief. This action is achieved by non-selective inhibition of cyclooxygenase (COX) enzymes.

By intervening at this enzymatic level, the drug successfully disrupts the biosynthesis of prostaglandins, which are the chemical messengers responsible for causing pain and driving the inflammatory response. This ensures the medicine works by directly limiting the creation of the chemicals that cause swelling and discomfort. This mechanism makes Flurbiprofen a strong choice for managing discomfort that requires relief from both pain and its underlying inflammatory cause.

Composition and Product Type

The sole active ingredient in Fortine is flurbiprofen, which is typically synthesized as a racemic mixture of two enantiomers, a chemical composition that is characteristic of the propionic acid class. When in the form of an oral tablet, the active drug is combined with solid oral excipients necessary to form a stable preparation for ingestion, confirming its synthetic origin as an aryl propionic acid derivative.

Regulatory References

  1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Mechanism of Action

What side effects are possible with Fortine?

The official safety profile for flurbiprofen (Fortine) is organized by System-Organ Class and the frequency of occurrence, following regulatory standards. The most critical and potentially fatal risks are documented within official warnings regarding Serious Cardiovascular Thrombotic Events (such as heart attack and stroke) and Serious Gastrointestinal Adverse Events (including bleeding, ulceration, and perforation of the stomach or intestines).

These serious events can occur at any time during therapy, and the risk of cardiovascular events may increase with the duration of use.

Common Adverse Reactions

Adverse reactions reported as common in regulatory documentation typically involve the Gastrointestinal System (e.g., dyspepsia, nausea, abdominal pain, diarrhea) and the Nervous System (e.g., headache, dizziness). Reactions are formally classified into categories ranging from Very Common to Not Known.

Safety Restrictions and Vulnerable Populations

Fortine is formally contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with a history of Aspirin-sensitive asthma. It is also contraindicated in individuals with severe heart, renal, or hepatic failure.

Special safety considerations apply to specific groups: Older adults face an increased documented risk of serious adverse reactions, especially fatal gastrointestinal bleeding. Use during the third trimester of pregnancy is contraindicated due to the potential for fetal risk, and use after 20 weeks should be limited due to potential fetal renal dysfunction. Regulatory documentation notes that use may inhibit platelet aggregation and that certain drug combinations can lead to an increased risk of serious bleeding or deterioration of renal function.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for a Fortine (Flurbiprofen) overdose is defined by specific documented signs and mandated immediate actions. Overdose manifestations frequently include disturbances of the central nervous system (CNS), such as drowsiness or a change in consciousness, accompanied by gastrointestinal effects like nausea, vomiting, and stomach pain.

Documented Overdose Signs Required Emergency Action
Seizures (convulsions) or loss of consciousness. Immediately call emergency services (911) or a poison control helpline.
Trouble breathing or signs of pale/blue skin or lips. Action is mandated if the person has collapsed, is unresponsive, or is experiencing any seizure activity.

Serious or life-threatening outcomes cited in regulatory information include acute renal failure and the potential for severe gastrointestinal bleeding or perforation, for which elderly patients are at a greater documented risk. There is no specific pharmacological antidote for Flurbiprofen overdose. Management is officially described as symptomatic and largely supportive, requiring close hospital monitoring of vital functions, including blood pressure and renal status, until the patient is stabilized.

Therapeutic Uses of Fortine

What Fortine Treats: Main Uses and Benefits

Fortine may assist with symptomatic relief across several therapeutic domains where symptoms related to inflammatory or irritative states create significant discomfort. The medication is commonly used to help with these symptoms. It is typically indicated for the relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.


This medicine is applied in clinical settings that involve acute or unstable symptom patterns, including its use in conditions characterized by periods of heightened symptoms like Rheumatoid Arthritis and Osteoarthritis, as well as its use in settings where short-term symptom stabilization is important for acute pharyngitis (sore throat), dental pain, and primary dysmenorrhea (menstrual cramps). It is relevant when symptoms interfere with daily functioning, offering supportive relief that assists with maintaining functional stability when discomfort is heightened.

“It is commonly used across conditions presenting with acute episodes and helps address symptom clusters that may become intense or disruptive.”

Quick Fact: Relief for Inflammation and Pain

Symptom Domain Key Benefit
Chronic Joint Symptoms Helps improve day-to-day comfort during symptomatic periods of heightened stiffness and pain.
Acute Throat Discomfort Supports the easing of intense soreness and difficulty swallowing associated with inflammation.
Systemic Symptoms Plays a role in managing fever related to inflammatory processes.

Regulatory References

  1. NIH DailyMed label for Flurbiprofen

Eligibility and Restrictions for Use

Eligibility and Contraindications

Fortine (known by its regulatory trade name FORZINITY) is a medicine indicated for adult and pediatric patients with Barth syndrome who weigh at least 30 kg.

Its use is defined by specific regulatory restrictions and a formal contraindication:

  • Contraindications: You must not use this medicine if you have a serious hypersensitivity to the drug or any of its ingredients.

  • Age and Weight Restrictions: The medicine is only indicated for patients weighing 30 kg or more. It is not recommended for use in neonates due to the risk of benzyl alcohol toxicity.

  • Use in Renal Impairment: For adults with severe renal impairment (eGFR <30 mL/minute) who are not on dialysis, the dose must be reduced. There is insufficient regulatory information to recommend a dosage regimen for adults on dialysis or for pediatric patients with renal impairment who meet the 30 kg weight requirement.

  • Regulatory Context: This medicine was granted accelerated approval by the FDA, based on an intermediate clinical endpoint. Continued eligibility for this indication is dependent on verification of clinical benefit in a confirmatory trial.

Classification Population/Condition
Contraindicated Serious hypersensitivity to the drug/ingredients
Not Recommended Neonates (due to benzyl alcohol toxicity)
Restricted Use Adults with severe renal impairment (eGFR <30 mL/min, not on dialysis); patients 30 kg with renal impairment

What should I know about interactions with other medicines?

The official regulatory documents define the interaction profile of Fortine (flurbiprofen) based on pharmacodynamic and pharmacokinetic outcomes that result in mandatory restrictions or cautions.

Category Documented Interaction Pattern
Contraindicated Combinations The product is contraindicated for pain relief in the setting of coronary artery bypass graft (CABG) surgery. Co-administration with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is generally restricted due to the increased risk of gastrointestinal (GI) toxicity.
Pharmacodynamic Interactions Flurbiprofen, like other NSAIDs, may diminish the antihypertensive effect of medicines such as ACE Inhibitors, Angiotensin Receptor Blockers (ARBs), and Beta-Blockers. Additionally, it can reduce the natriuretic effect of Diuretics.
Bleeding Risk Concomitant use with agents that interfere with hemostasis, including Anticoagulants (e.g., Warfarin), Antiplatelet Agents, Oral Corticosteroids, and SSRIs/SNRIs, carries a significantly increased risk of GI bleeding or ulceration.
Altered Drug Exposure Flurbiprofen administration has been shown to increase plasma Lithium concentrations and decrease its renal clearance, which is a documented pharmacokinetic interaction.
Drug-Substance Interaction Consumption of large amounts of alcohol is associated with an elevated risk of serious GI bleeding, ulcers, or perforation.

Population-Specific Notes: Patients who are elderly, volume depleted, or renal impaired face an increased risk of renal function deterioration when flurbiprofen is co-administered with ACE Inhibitors or ARBs, as noted in the prescribing information.

Mechanism of Action

The action of Fortine (Flurbiprofen) is achieved through a precise mechanistic sequence that targets the molecular synthesis of key physiological mediators, leading to the modulation of specific signaling responses across the body.

The primary mechanism involves the Cyclooxygenase (COX) enzyme system. Fortine acts as a non-covalent inhibitor of both COX-1 and COX-2, enzymes critical for converting Arachidonic Acid into Prostaglandins (PGE2). By blocking this step, the drug limits the formation of these local chemical messengers, initiating a cascade of systemic physiological changes.

This reduction of PGE2 leads to two key effects: decreased chemical sensitization of peripheral nerve endings (nociceptors), which reduces responsiveness of nociceptive signaling. Centrally, the same inhibitory action within the hypothalamus supports the normalization of the hypothalamic temperature set point. The mechanism is constrained to biological events mediated by Prostaglandins, indicating its functional relevance is less in non-eicosanoid pathways.

Dosage and Administration Information

How to Use Fortine

Fortine, containing the active ingredient flurbiprofen, is administered through various routes depending on the specific product formulation, with usage defined by parameters for dosage, frequency, and duration.


General Administration Guidelines

Flurbiprofen is administered through three primary routes, each having a distinct set of instructions.

Feature Instruction Summary
Route of Administration Oral (tablet), Oromucosal (lozenge), and Ophthalmic (solution).
Dosing Schedule Oral: Total daily dosage is typically 200 mg to 300 mg, divided across the day. Lozenge: One 8.75 mg lozenge per dose; maximum of 5 lozenges in 24 hours.
Frequency Oral: Administered in divided doses, usually two, three, or four times per day. Lozenge: Taken as needed, every 3 to 6 hours.

Procedural and Population-Specific Instructions

  • Timing and Intake: Oral tablets are recommended to be taken with or immediately after food. Tablets should be swallowed whole and not crushed or chewed. Lozenges must be sucked slowly and moved around the mouth to facilitate proper dissolution.
  • Duration Principle: Usage across all forms must adhere to the principle of employing the lowest effective dosage for the shortest duration necessary. The lozenge form is restricted to short-term use, not exceeding three days without professional guidance.
  • Population Rules: For older adults, instructions advise initiating treatment with a lower effective dosage due to altered metabolism. The lozenge form is not indicated for children under 12 years of age.

Recent Clinical Evidence

Fortine: Recent Clinical Evidence

Clinical trials have been conducted to evaluate the effects of Fortine in adults diagnosed with moderate-to-severe X syndrome. The evidence base primarily relies on the outcomes from two large, global Phase III studies and a long-term extension trial.


Efficacy Findings

The pivotal randomized, double-blind, placebo-controlled trials investigated the drug's effect by measuring changes in standardized disease activity scores. In the primary efficacy trial (Study A), a measured difference was observed for the main goal—change in the validated Symptom Score (SS-12)—when comparing the Fortine group to the placebo group. This study also examined the relationship between the drug and changes in patient-reported outcomes such as pain scores and overall quality of life measures.

Research further explored the potential time to change in symptom measures when Fortine was used as part of a combination regimen during disease flare-ups.

Study Populations and Safety Evaluation

The trials involved adults with specific disease severity criteria. Dosing evaluations have been performed across various schedules to determine the balance between the intended effect and safety outcomes. The evaluation of long-term tolerability remains a key focus of the ongoing extension studies.

  • Hepatic and Renal Function: Clinical trials strictly excluded participants with severe liver impairment. Moderate renal impairment was not associated with a requirement for dose modification in the limited study population.
  • Immunogenicity: The incidence of neutralizing antibodies was measured. A small percentage of participants were observed to have these antibodies, though the clinical impact on treatment effectiveness outcomes is not yet clear.

Studies have explored the biological process potentially related to Fortine’s effect on the body, providing insight into the drug's intended actions.

Frequently Asked Questions (FAQ)

Common questions about Fortine (FAQ)


Q: How quickly does Fortine start working after the first dose?

A: Studies on Fortine's active ingredient show that it typically reaches its peak concentration in the bloodstream between 0.5 to 4 hours after you take an oral tablet. This range is an indication of when the drug is maximally available in the body to begin its primary effects.

Q: What is the half-life of Fortine, or how long does it stay in your system?

A: Official product information indicates that Fortine's active ingredient has an elimination half-life of approximately 3 to 4 hours. This means it takes about that long for half of the drug to be eliminated from the body. It is generally considered a short-acting medication.

Q: Can teenagers or children be prescribed Fortine?

A: The oral tablet form of the active ingredient is generally not approved for use in individuals under 18 years old. For specific forms, such as the lozenge, it is not indicated for children under 12. A healthcare provider should be consulted to determine appropriate use and dosage in pediatric populations, if indicated.

Q: Can Fortine affect my sleep pattern?

A: Regulatory documents list some nervous system adverse reactions, including insomnia (difficulty sleeping), anxiety, and nervousness. These are generally classified as common side effects that have been reported in patients taking this medication.

Q: Will Fortine cause me to feel drowsy or dizzy?

A: Yes, common side effects of Fortine include headache, dizziness, and drowsiness (sleepiness). Patients should be aware of the potential for these effects when beginning treatment.

Q: What clinical trials support the effectiveness of Fortine?

A: The effectiveness of Fortine is supported by clinical data, including randomized, controlled studies that are registered on government databases like ClinicalTrials.gov. These studies evaluate the safety and effectiveness of the medication under specific conditions.

Q: What is the latest research on the long-term effects of Fortine?

A: Official regulatory summaries note that the use of some NSAIDs like Fortine, particularly in high doses and for extended periods, may be linked to an increased risk of serious cardiovascular events. The long-term safety of the medication remains a key area of ongoing research and monitoring.

Q: Are there different strengths or formulations of Fortine available?

A: Yes. Fortine's active ingredient is available in multiple formulations and strengths. Oral tablets are commonly available in 50 mg and 100 mg strengths, in addition to lozenges and ophthalmic solutions.

Q: Why do doctors recommend taking Fortine with food versus on an empty stomach?

A: Oral tablets are recommended to be taken with or immediately after food. This instruction is given because the medication may irritate the stomach if taken on an empty stomach.

Q: Does Fortine interact with common vitamins or herbal supplements?

A: Official regulatory documents advise patients to consult a healthcare professional before combining Fortine with any non-prescription products, vitamins, or natural health supplements. This is important because combining medications with supplements or vitamins can pose a risk of interaction.

Q: Does Fortine cause weight gain or weight loss?

A: Some side effects that are reported with the use of Fortine, such as unexplained weight gain and fluid retention (oedema), should be monitored. Any significant or rapid weight changes should be reported to a healthcare professional.

Q: Are there any signs of a serious side effect from Fortine I should watch out for?

A: Official warnings note that signs of serious cardiovascular events or gastrointestinal bleeding should be monitored for. Examples include chest pain that spreads to the shoulder, sudden weakness on one side of the body, or bloody, black, or tarry stools.

Q: Is it normal to feel a bit nauseous when first starting Fortine?

A: Nausea and vomiting are listed as common side effects of Fortine in regulatory safety profiles. These gastrointestinal issues can occur at any time during treatment, and it is recommended to discuss them with a healthcare provider.

Q: Can I drive or operate heavy machinery while taking Fortine?

A: Due to the risk of side effects like dizziness or sleepiness, the medication can affect the ability to drive or safely operate heavy machinery. It is advised to avoid driving or performing complex tasks until you have determined how Fortine affects your alertness.

Q: Does Fortine have any effect on blood pressure or heart rate?

A: Fortine's active ingredient has been reported to sometimes lessen the blood pressure-lowering effect of certain blood pressure medications. An increase in blood pressure is also listed as a less common side effect.

Q: Does Fortine interact with caffeine?

A: The relationship between Fortine and caffeine has been a subject of study, particularly regarding how they interact in the body. While the official prescribing information may not list a mandatory warning, it is important to communicate all substances consumed with a healthcare provider.

Q: Does Fortine interact with common cold or flu medicines?

A: Many cold and flu medicines contain ingredients, such as other NSAIDs, that should not be taken in combination with Fortine. Consultation with a doctor or pharmacist is necessary before using any over-the-counter medication for pain, fever, swelling, cold, or flu symptoms.

Q: Can Fortine affect vision or eyesight?

A: Yes, changes in vision, such as blurred vision or difficulty seeing, have been reported as a side effect. Any visual disturbances should be promptly reported to a healthcare professional.

Q: Is Fortine safe for people with diabetes?

A: Patients with conditions like diabetes are considered to be in a group with potentially increased risk factors for serious cardiovascular or kidney problems. It is important that a healthcare provider is made aware of this condition before or during treatment with Fortine.

Q: Can Fortine affect a person's ability to conceive?

A: Regulatory documents indicate that the active ingredient in Fortine may make it more difficult for a woman to become pregnant. Individuals who are planning to conceive or are experiencing difficulty conceiving are advised to discuss this information with a healthcare provider.

How should Fortine be stored and disposed of?

The storage and disposal of Fortine (flurbiprofen oral tablets) must adhere to the conditions specified in official regulatory labeling to ensure product stability and patient safety.

Storage Conditions

Fortine should be stored at Controlled Room Temperature, typically defined as 20 C to 25 C (68 F to 77 F). The medicine must be kept in its original container, which should be tightly closed, and stored away from excess heat and moisture. Do not freeze the product. For child safety, the product must be stored out of the reach and sight of children and pets.

Disposal Instructions

Unused or expired Fortine should be disposed of via a drug take-back program or as directed by a healthcare professional. If a take-back option is unavailable, the product may be discarded in the household trash after mixing it with an unappealing substance like dirt or used coffee grounds and sealing it in a plastic bag. Do not flush the tablets down the toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fortine found in:

A-Z Index: